INS and diabetes mellitus: VSG was well-tolerated in this age group, and within 3 months, VSG induced notable improvements in weight, body composition, SI and insulin secretion, glucose tolerance, FFA suppression and fat oxidation, glycemic control, and cardiometabolic health, including diabetes remission in the majority, supporting consideration of VSG for weight and metabolic management in this high-risk population.